Citation Impact
Citing Papers
The Role of Hypoxia in Vascular Injury and Repair
2008
Use of mass media campaigns to change health behaviour
2010 Standout
Induction of Vascular Endothelial Growth Factor by Insulin-like Growth Factor 1 in Colorectal Carcinoma
1996
Subcutaneous injection of a cyclic peptide antagonist of vitronectin receptor–type integrins inhibits retinal neovascularization
1996
The Retinal Pigment Epithelium in Visual Function
2005 Standout
Diabetic retinopathy
2010 Standout
Aflibercept, Bevacizumab, or Ranibizumab for Diabetic Macular Edema
2015 Standout
VEGF couples hypertrophic cartilage remodeling, ossification and angiogenesis during endochondral bone formation
1999 Standout
Inducer-stimulated Fas targets activated endothelium for destruction by anti-angiogenic thrombospondin-1 and pigment epithelium–derived factor
2002 Standout
Ranibizumab for Neovascular Age-Related Macular Degeneration
2006 Standout
Retinopathy of prematurity
2013 Standout
Paclitaxel–Carboplatin Alone or with Bevacizumab for Non–Small-Cell Lung Cancer
2006 Standout
Isolation of Angiopoietin-1, a Ligand for the TIE2 Receptor, by Secretion-Trap Expression Cloning
1996 Standout
Vascular Endothelial Growth Factor Regulates Endothelial Cell Survival through the Phosphatidylinositol 3′-Kinase/Akt Signal Transduction Pathway
1998 Standout
Mouse mutant embryos overexpressing IGF-II exhibit phenotypic features of the Beckwith–Wiedemann and Simpson–Golabi–Behmel syndromes
1997
Regulation of Cardiovascular Development and Physiology by Hypoxia‐Inducible Factor 1a
1999 StandoutNobel
The biology of VEGF and its receptors
2003 Standout
Insulin-like Growth Factor 1 Induces Hypoxia-inducible Factor 1-mediated Vascular Endothelial Growth Factor Expression, Which is Dependent on MAP Kinase and Phosphatidylinositol 3-Kinase Signaling in Colon Cancer Cells
2002 StandoutNobel
Age-dependent Defect in Vascular Endothelial Growth Factor Expression Is Associated with Reduced Hypoxia-inducible Factor 1 Activity
2000 StandoutNobel
A Review of Cervical Cancer Screening Intervention Research: Implications for Public Health Programs and Future Research
1998
Methylation of a CTCF-dependent boundary controls imprinted expression of the Igf2 gene
2000 StandoutNature
Angiogenesis: mechanistic insights, neovascular diseases, and therapeutic prospects
1995
Diabetic Retinopathy
2012 Standout
Regulation of Hypoxia-Inducible Factor-1α, Vascular Endothelial Growth Factor, and Angiogenesis by an Insulin-Like Growth Factor-I Receptor Autocrine Loop in Human Pancreatic Cancer
2003 StandoutNobel
Localization of Collagen XVIII and the Endostatin Portion of Collagen XVIII in Aged Human Control Eyes and Eyes with Age-Related Macular Degeneration
2004
Vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematurity
1995 Standout
Basement membrane and growth factor gene expression in normal and diabetic human retinas
1999
Clinical Applications of Research on Angiogenesis
1995 Standout
Vascular Endothelial Growth Factor in Ocular Fluid of Patients with Diabetic Retinopathy and Other Retinal Disorders
1994 Standout
Paclitaxel plus Bevacizumab versus Paclitaxel Alone for Metastatic Breast Cancer
2007 Standout
Regulation of vascular endothelial growth factor by hypoxia and its modulation by the von Hippel-Lindau tumor suppressor gene
1997 StandoutNobel
Expression of the angiogenic mediator, angiopoietin-like 4, in the eyes of patients with proliferative sickle retinopathy
2017 StandoutNobel
Vascular-specific growth factors and blood vessel formation
2000 StandoutNature
Insulin, insulin analogues and diabetic retinopathy
2008
The role of vascular endothelial growth factor in pathological angiogenesis
1995
Requisite Role of Angiopoietin-1, a Ligand for the TIE2 Receptor, during Embryonic Angiogenesis
1996 Standout
Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia
2003 Standout
Antitumor Activity of Thalidomide in Refractory Multiple Myeloma
1999 Standout
Basic Fibroblast Growth Factor and Vascular Endothelial Growth Factor Are Present in Epiretinal and Choroidal Neovascular Membranes
1996
Rapamycin inhibits primary and metastatic tumor growth by antiangiogenesis: involvement of vascular endothelial growth factor
2002 Standout
Cellular and developmental control of O2 homeostasis by hypoxia-inducible factor 1α
1998 StandoutNobel
Pegaptanib for Neovascular Age-Related Macular Degeneration
2004 Standout
Client-Directed Interventions to Increase Community Demand for Breast, Cervical, and Colorectal Cancer Screening
2008
Regulation of vascular endothelial growth factor-dependent retinal neovascularization by insulin-like growth factor-1 receptor
1999
Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene
1996 StandoutNature
Carbon Monoxide and Nitric Oxide Suppress the Hypoxic Induction of Vascular Endothelial Growth Factor Gene via the 5′ Enhancer
1998 StandoutNobel
Neuropilin-1 Is Expressed by Endothelial and Tumor Cells as an Isoform-Specific Receptor for Vascular Endothelial Growth Factor
1998 Standout
LRG1 promotes angiogenesis by modulating endothelial TGF-β signalling
2013 StandoutNature
Patient Education for Colon Cancer Screening: A Randomized Trial of a Video Mailed before a Physical Examination
2004
HIF-1: mediator of physiological and pathophysiological responses to hypoxia
2000 StandoutNobel
Serpin Structure, Mechanism, and Function
2002 Standout
Vascular Endothelial Growth Factor: Basic Science and Clinical Progress
2004 Standout
Prevention of ischemia-induced retinopathy by the natural ocular antiangiogenic agent pigment epithelium-derived factor
2001
Essential Role of Growth Hormone in Ischemia-Induced Retinal Neovascularization
1997 Science
The Biology of Vascular Endothelial Growth Factor
1997 Standout
Decision aids for people facing health treatment or screening decisions
2017 Standout
HER2 (neu) Signaling Increases the Rate of Hypoxia-Inducible Factor 1α (HIF-1α) Synthesis: Novel Mechanism for HIF-1-Mediated Vascular Endothelial Growth Factor Expression
2001 StandoutNobel
Nonsteroidal anti‐inflammatory drugs prevent early diabetic retinopathy via TNF‐α suppression
2002
Cancer Treatment by Targeted Drug Delivery to Tumor Vasculature in a Mouse Model
1998 StandoutScience
Pigment Epithelium-Derived Factor: A Potent Inhibitor of Angiogenesis
1999 StandoutScience
Mechanisms of Diabetic Complications
2013 Standout
Elevation of vitreous leptin in diabetic retinopathy and retinal detachment.
2000
Hypoxic retinal Müller cells promote vascular permeability by HIF-1–dependent up-regulation of angiopoietin-like 4
2013 StandoutNobel
Informed decision making: an annotated bibliography and systematic review.
1999
Growth factors and their receptors in the retina and pigment epithelium
1997
Diabetic Retinopathy
2004
Insulin-like Growth Factor-I and its Receptor in Neovascular Age-Related Macular Degeneration
2003
HIF-1 and human disease: one highly involved factor
2000 StandoutNobel
Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins.
1995 Standout
Effects of Disturbed Flow on Vascular Endothelium: Pathophysiological Basis and Clinical Perspectives
2011 Standout
IGFBP3 suppresses retinopathy through suppression of oxygen-induced vessel loss and promotion of vascular regrowth
2007
Role of the Vascular Endothelial Growth Factor Pathway in Tumor Growth and Angiogenesis
2004 Standout
Works of Matthew Klein being referenced
Vitreous levels of the insulin-like growth factors I and II, and the insulin-like growth factor binding proteins 2 and 3, increase in neovascular eye disease. Studies in nondiabetic and diabetic subjects.
1993
Increased Cancer Screening Behavior in Women of Color by Culturally Sensitive Video Exposure
1995
Deficient activation and different expression of transforming growth factor-β isoforms in active proliferative diabetic retinopathy and neovascular eye disease
2009
[TNF-alpha level in the vitreous body. Increase in neovascular eye diseases and proliferative diabetic retinopathy].
1995